Laurence M. Corash - Dec 13, 2021 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Menard, attorney-in-fact
Stock symbol
CERS
Transactions as of
Dec 13, 2021
Transactions value $
$150,000
Form type
4
Date filed
12/15/2021, 07:57 PM
Next filing
Dec 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Common Stock Options Exercise $150K +40K +2.02% $3.75 2.02M Dec 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERS Option (Right to Buy) Options Exercise -40K -88.89% 5K Dec 13, 2021 Common Stock 40K $3.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter.
F2 Not applicable.